Systematic review protocol: An assessment of the post-approval challenges of autologous CAR-T therapy delivery
Lam C., MEINERT E., Halioua-Haubold C-L., CARTER A., YANG A., BRINDLEY D.
Following recent regulatory approvals of two chimeric antigen receptor T-cell (CAR-T) therapies, the field now faces a number of post-approval challenges. These challenges are in some respects defined and, in others, uncertain due to the nascence of the field. At present, information pertaining to such post-approval challenges are scattered in various previous reviews or raised in singular papers reporting experience in working with the therapy. This systematic review is designed to evaluate and summarise the post-approval challenges for robust delivery of CAR-T therapies to inform future work on the optimisation of CAR-T delivery to patients.